Summary & Overview
HCPCS C9739: Cystourethroscopy with Transprostatic Implant, 1–3 Implants
HCPCS Level II code C9739 denotes cystourethroscopy with insertion of transprostatic implant(s) — specifically placement of one to three implants during an endoscopic urologic procedure. The code captures a minimally invasive approach to address prostatic obstruction or related lower urinary tract conditions by delivering intraprostatic implants under cystoscopic guidance. Nationally, this code is relevant as device-based, office-to-ambulatory-site procedures expand and payers refine coverage and reimbursement policies for urologic implants.
Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise national overview of the clinical service represented by the code, common sites of service, and typical billing context. The publication also summarizes benchmark considerations and policy themes payers address for implantable urologic therapies, outlines coding and documentation implications, and highlights areas where payers commonly require additional clinical evidence or prior authorization.
This summary is designed to give clinicians, billing staff, and policy analysts a clear, actionable understanding of what C9739 represents, why it matters in the evolving landscape of urologic device-based care, and what topics to review when preparing claims or evaluating coverage.
Billing Code Overview
HCPCS Level II code C9739 describes cystourethroscopy with insertion of transprostatic implant, 1 to 3 implants. This procedure involves endoscopic visualization of the urethra and bladder (cystourethroscopy) combined with placement of one to three transprostatic implants intended to treat obstructive prostatic symptoms or related urologic conditions.
-
Service type: Surgical endoscopic procedure with implant placement
-
Typical site of service: Ambulatory surgical center or hospital outpatient department for urologic endoscopic intervention
Clinical & Coding Specifications
Clinical Context
A 67-year-old male with symptomatic benign prostatic hyperplasia (BPH) presents with recurrent lower urinary tract symptoms (LUTS) including weak urinary stream, nocturia, and incomplete bladder emptying despite medical therapy. After urologic evaluation including prostate-specific antigen testing, urinalysis, and transrectal ultrasound showing an enlarged transition zone, the patient elects to undergo cystourethroscopy with transprostatic implant insertion to relieve bladder outlet obstruction.
The clinical workflow: preoperative assessment and informed consent are completed in clinic; perioperative antibiotics are administered per facility protocol; the patient is brought to the ambulatory surgery center or hospital operating room; under regional or general anesthesia, cystourethroscopy is performed to visualize the urethra and prostatic urethra; transprostatic implants (1–3) are placed under direct visualization through a cystoscopic delivery system; hemostasis is confirmed, and the patient is observed in recovery for voiding trials and discharged same day or admitted overnight for observation if indicated.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier — standard service | Use when no special circumstances apply. |
22 |